Works matching IS 18696953 AND DT 2022 AND VI 13 AND IP 5

Results: 22

Observational Study on Unhealthy Eating Behavior and the Effect of Sodium-Glucose Cotransporter 2 Inhibitors: The Luseogliflozin Ehime Diabetes Study.

Published in:

Diabetes Therapy, 2022, v. 13, n. 5, p. 1073, doi. 10.1007/s13300-022-01261-9

By:

Furukawa, Shinya;
Miyake, Teruki;
Miyaoka, Hiroaki;
Matsuura, Bunzo;
Hiasa, Yoichi

Publication type:

Article

Mortality in People with Type 2 Diabetes Following SARS-CoV-2 Infection: A Population Level Analysis of Potential Risk Factors.

Published in:

Diabetes Therapy, 2022, v. 13, n. 5, p. 1037, doi. 10.1007/s13300-022-01259-3

By:

Heald, Adrian H.;
Jenkins, David A.;
Williams, Richard;
Sperrin, Matthew;
Mudaliar, Rajshekhar N.;
Syed, Akheel;
Naseem, Asma;
Bowden Davies, Kelly A.;
Peng, Yonghong;
Peek, Niels;
Ollier, William;
Anderson, Simon G.;
Delanerolle, Gayathri;
Gibson, J. Martin

Publication type:

Article

The Emerging Role of Continuous Glucose Monitoring in the Management of Diabetic Peripheral Neuropathy: A Narrative Review.

Published in:

Diabetes Therapy, 2022, v. 13, n. 5, p. 931, doi. 10.1007/s13300-022-01257-5

By:

Gouveri, Evanthia;
Papanas, Nikolaos

Publication type:

Article

Testosterone Deficiency is Not Protective Against the Development of Adenocarcinoma of the Prostate in a Type 1 Diabetic Patient.

Published in:

Diabetes Therapy, 2022, v. 13, n. 5, p. 1115, doi. 10.1007/s13300-022-01256-6

By:

Bell, David S. H.;
Jerkins, Terri

Publication type:

Article

Biosimilar Insulin Aspart Premix SAR341402 Mix 70/30 Versus Originator Insulin Aspart Mix 70/30 (NovoMix 30) in People with Diabetes: A 26-Week, Randomized, Open-Label Trial (GEMELLI M).

Published in:

Diabetes Therapy, 2022, v. 13, n. 5, p. 1053, doi. 10.1007/s13300-022-01255-7

By:

Aravind, S. R.;
Singh, Kiran P.;
Aquitania, Grace;
Mogylnytska, Liliia;
Zalevskaya, Alsu G.;
Matyjaszek-Matuszek, Beata;
Wernicke-Panten, Karin;
Nguyên-Pascal, My-Liên;
Pierre, Suzanne;
Rotthaeuser, Baerbel;
Kramer, Daniel;
Mukherjee, Bhaswati

Publication type:

Article

Self-Monitoring of Blood Glucose as an Integral Part in the Management of People with Type 2 Diabetes Mellitus.

Published in:

Diabetes Therapy, 2022, v. 13, n. 5, p. 829, doi. 10.1007/s13300-022-01254-8

By:

Pleus, Stefan;
Freckmann, Guido;
Schauer, Sebastian;
Heinemann, Lutz;
Ziegler, Ralph;
Ji, Linong;
Mohan, Viswanathan;
Calliari, Luis Eduardo;
Hinzmann, Rolf

Publication type:

Article

A Response to: Letter to the Editor with Regard to the Cost-Effectiveness of an Advanced Hybrid Closed-Loop System in People with Type 1 Diabetes: A Health Economic Analysis in Sweden.

Published in:

2022

By:

Jendle, J.;
Buompensiere, M. I.;
Holm, A. L.;
de Portu, S.;
Malkin, S. J. P.;
Cohen, O.

Publication type:

Letter

Cost-Effectiveness of Intermittently Scanned Continuous Glucose Monitoring Versus Advanced Hybrid Closed-Loop Systems in Type 1 Diabetes: Comment on Jendle et al.

Published in:

2022

By:

Levrat-Guillen, Fleur;
Ghazi, Tara

Publication type:

Letter

Effects of Pentoxifylline on Serum Markers of Diabetic Nephropathy in Type 2 Diabetes.

Published in:

Diabetes Therapy, 2022, v. 13, n. 5, p. 1023, doi. 10.1007/s13300-022-01250-y

By:

Moosaie, Fatemeh;
Rabizadeh, Soghra;
Fallahzadeh, Aida;
Sheikhy, Ali;
Meysamie, Alipasha;
Dehghani Firouzabadi, Fatemeh;
Nakhjavani, Manouchehr;
Esteghamati, Alireza

Publication type:

Article

The FIDELIO Study Podcast.

Published in:

Diabetes Therapy, 2022, v. 13, n. 5, p. 823, doi. 10.1007/s13300-022-01249-5

By:

Toto, Robert;
Bakris, George

Publication type:

Article

Correction to: Cost-Effectiveness Evaluation of a Remote Monitoring Programme Including Lifestyle Education Software in Type 2 Diabetes: Results of the Educ@dom Study.

Published in:

2022

By:

Mounié, Michael;
Costa, Nadège;
Gourdy, Pierre;
Latorre, Christelle;
Schirr-Bonnans, Solène;
Lagarrigue, Jean-Marc;
Roussel, Henri;
Martini, Jacques;
Buisson, Jean-Christophe;
Chauchard, Marie-Christine;
Delaunay, Jacqueline;
Taoui, Soumia;
Poncet, Marie-France;
Cosma, Valeria;
Lablanche, Sandrine;
Coustols-Valat, Magali;
Chaillous, Lucie;
Thivolet, Charles;
Sanz, Caroline;
Penfornis, Alfred

Publication type:

Correction Notice

Clinical Use of Insulin Glargine 300 U/mL in Adults with Type 2 Diabetes: Hypothetical Case Studies.

Published in:

Diabetes Therapy, 2022, v. 13, n. 5, p. 913, doi. 10.1007/s13300-022-01247-7

By:

Harris, Stewart B.;
Parente, Erika B.;
Karalliedde, Janaka

Publication type:

Article

A Therapeutic Vibrating Insole Device for Postural Instability in Older People with Type 2 Diabetes: A Randomized Control Study.

Published in:

Diabetes Therapy, 2022, v. 13, n. 5, p. 995, doi. 10.1007/s13300-022-01246-8

By:

Bourdel-Marchasson, Isabelle;
Regueme, Sophie C.;
Kelson, Mark;
Poustis, Joël;
Barralon, Pierre;
Laosa, Olga;
Rodriguez-Mañas, Leocadio;
Sinclair, Alan J.

Publication type:

Article

Impact of My Dose Coach App Frequency of Use on Clinical Outcomes in Type 2 Diabetes.

Published in:

Diabetes Therapy, 2022, v. 13, n. 5, p. 983, doi. 10.1007/s13300-022-01245-9

By:

Unnikrishnan, Ambika Gopalakrishnan;
Viswanathan, Vijay;
Zhou, Fang Liz;
Hao, Lichen;
Kamath, Prithvi;
Bertolini, Monica;
Botero, Jose Fernando;
Mancillas-Adame, Leonardo

Publication type:

Article

The Prevalence of Cardiovascular Disease in Adults with Type 2 Diabetes in China: Results from the Cross-Sectional CAPTURE Study.

Published in:

Diabetes Therapy, 2022, v. 13, n. 5, p. 969, doi. 10.1007/s13300-022-01243-x

By:

Hong, Tianpei;
Yan, Zongxun;
Li, Li;
Tang, Wei;
Qi, Lin;
Ye, Jianhua;
Ren, Jiangong;
Wan, Qin;
Xiao, Wenhua;
Zhao, Di

Publication type:

Article

Defining the Role of SGLT2 Inhibitors in Primary Care: Time to Think Differently.

Published in:

Diabetes Therapy, 2022, v. 13, n. 5, p. 889, doi. 10.1007/s13300-022-01242-y

By:

Evans, Marc;
Morgan, Angharad R.;
Bain, Stephen C.;
Davies, Sarah;
Dashora, Umesh;
Sinha, Smeeta;
Seidu, Samuel;
Patel, Dipesh C.;
Beba, Hannah;
Strain, W. David

Publication type:

Article

Level of Agreement and Correlation Between the Estimated Hemoglobin A1c Results Derived by Continuous or Conventional Glucose Monitoring Systems Compared with the Point-of-Care or Laboratory-Based Measurements: An Observational Study.

Published in:

Diabetes Therapy, 2022, v. 13, n. 5, p. 953, doi. 10.1007/s13300-022-01240-0

By:

Al Hayek, Ayman A.;
Sobki, Samia H.;
Al-Saeed, Abdulghani H.;
Alzahrani, Wael M.;
Al Dawish, Mohamed A.

Publication type:

Article

Additional Effect of Luseogliflozin on Semaglutide in Nonalcoholic Steatohepatitis Complicated by Type 2 Diabetes Mellitus: An Open-Label, Randomized, Parallel-Group Study.

Published in:

Diabetes Therapy, 2022, v. 13, n. 5, p. 1083, doi. 10.1007/s13300-022-01239-7

By:

Miyake, Teruki;
Yoshida, Osamu;
Matsuura, Bunzo;
Furukawa, Shinya;
Hirooka, Masashi;
Abe, Masanori;
Tokumoto, Yoshio;
Koizumi, Yohei;
Watanabe, Takao;
Takeshita, Eiji;
Sunago, Kotaro;
Yukimoto, Atsushi;
Watanabe, Kyoko;
Miyazaki, Masumi;
Kanzaki, Sayaka;
Nakaguchi, Hironobu;
Koizumu, Mitsuhito;
Yamamoto, Yasunori;
Kumagi, Teru;
Hiasa, Yoichi

Publication type:

Article

Beyond the Glycaemic Control of Dapagliflozin: Microangiopathy and Non-classical Complications.

Published in:

Diabetes Therapy, 2022, v. 13, n. 5, p. 873, doi. 10.1007/s13300-022-01237-9

By:

Bellido, Virginia;
Martínez, Julia;
Calvo, Fernando;
Villarroel, Aida;
Lecumberri, Edurne;
Moreno, Juan;
Morillas, Carlos;
Rodrigo, Silvia;
Izarra, Aitziber;
Lecube, Albert

Publication type:

Article

The Risk Factors Potentially Influencing Hospital Admission in People with Diabetes, Following SARS-CoV-2 Infection: A Population-Level Analysis.

Published in:

Diabetes Therapy, 2022, v. 13, n. 5, p. 1007, doi. 10.1007/s13300-022-01230-2

By:

Heald, Adrian H.;
Jenkins, David A.;
Williams, Richard;
Sperrin, Matthew;
Fachim, Helene;
Mudaliar, Rajshekhar N.;
Syed, Akheel;
Naseem, Asma;
Gibson, J. Martin;
Bowden Davies, Kelly A.;
Peek, Niels;
Anderson, Simon G.;
Peng, Yonghong;
Ollier, William

Publication type:

Article

The Place and Value of Sodium-Glucose Cotransporter 2 Inhibitors in the Evolving Treatment Paradigm for Type 2 Diabetes Mellitus: A Narrative Review.

Published in:

Diabetes Therapy, 2022, v. 13, n. 5, p. 847, doi. 10.1007/s13300-022-01228-w

By:

Wilding, John P. H.;
Evans, Marc;
Fernando, Kevin;
Gorriz, Jose Luis;
Cebrian, Ana;
Diggle, Jane;
Hicks, Debbie;
James, June;
Newland-Jones, Philip;
Ali, Amar;
Bain, Stephen;
Da Porto, Andrea;
Patel, Dipesh;
Viljoen, Adie;
Wheeler, David C.;
Del Prato, Stefano

Publication type:

Article

Expert Opinion: Optimum Clinical Approach to Combination-Use of SGLT2i + DPP4i in the Indian Diabetes Setting.

Published in:

Diabetes Therapy, 2022, v. 13, n. 5, p. 1097, doi. 10.1007/s13300-022-01219-x

By:

Chadha, Manoj;
Das, Ashok Kumar;
Deb, Prasun;
Gangopadhyay, Kalyan Kumar;
Joshi, Shashank;
Kesavadev, Jothydev;
Kovil, Rajiv;
Kumar, Surender;
Misra, Anoop;
Mohan, Viswanathan

Publication type:

Article